Vincerx Pharma is a clinical-stage biopharmaceutical company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer.
Data Provided by Refinitiv. Minimum 15 minutes delayed.
The stock information provided is for informational purposes only and is not intended for trading purposes. The stock information is provided by a third party service, and Vincera Pharma, Inc. does not maintain or provide information directly to this service.
Mar 14, 2023
Feb 06, 2023
Dec 13, 2022
Feb 16, 2023 at 1:40 PM EST
Feb 17, 2022 at 1:40 PM EST
Dec 11, 2021 at 7:30 PM EST